334 related articles for article (PubMed ID: 23431363)
1. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
Yu L; Chang K; Han J; Deng S; Chen M
PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
[TBL] [Abstract][Full Text] [Related]
2. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
3. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.
Wu CY; Yang M; Lin M; Li LP; Wen XZ
Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325
[TBL] [Abstract][Full Text] [Related]
4. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.
Luo YL; Ye P; Zhang QH; Hu TT; Luo MH; Li MQ; Chen Q
PLoS One; 2012; 7(9):e46272. PubMed ID: 23029458
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
Xu R; Wu H; Zhang S; Zhou H; Liang L
Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
[TBL] [Abstract][Full Text] [Related]
9. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
[TBL] [Abstract][Full Text] [Related]
10. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
Yan Y; Han F; Fu H; Xia W; Qin X
Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
[TBL] [Abstract][Full Text] [Related]
11. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies.
Wu YL; Ding XX; Sun YH; Yang HY; Chen J; Zhao X; Jiang YH; Lv XL; Wu ZQ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():78-85. PubMed ID: 23831680
[TBL] [Abstract][Full Text] [Related]
12. The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis.
Mei Q; Zhou D; Gao J; Shen S; Wu J; Guo L; Liang Z
BMC Cancer; 2012 Oct; 12():467. PubMed ID: 23057736
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.
Xu XJ; Zou LW; Wang DB
Mol Biol Rep; 2013 Jan; 40(1):255-62. PubMed ID: 23070908
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.
Silva NNT; Sabino AP; Tafuri A; Lima AA
BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
16. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.
Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W
Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883
[TBL] [Abstract][Full Text] [Related]
17. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
Ma C; Liu Y; Zhang W; Liu P
Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
[TBL] [Abstract][Full Text] [Related]
18. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
19. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
Liu L; Yu Y; He J; Guo L; Li H; Teng J
Headache; 2019 Jun; 59(6):891-905. PubMed ID: 31045246
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
